Skip to main content
. 2015 Mar 1;32(5):342–352. doi: 10.1089/neu.2014.3548

FIG. 7.

FIG. 7.

Detection of T-tau and P-tau in human cerebrospinal fluid (1:100 dilution) during the acute and chronic phases post severe brain injury using enhanced immunoassay using multi-arrayed fiberoptics coupled to rolling circle amplification (A) and enzyme-linked immunosorbent assay (B).